BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17203106)

  • 21. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
    Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
    Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
    Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
    Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model.
    Miyahara R; Banerjee S; Kawano K; Efferson C; Tsuda N; Miyahara Y; Ioannides CG; Chada S; Ramesh R
    Cancer Gene Ther; 2006 Aug; 13(8):753-61. PubMed ID: 16543916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
    Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
    Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
    Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cell vaccine therapy by immunization with fusion cells of interleukin-2 gene-transduced, spleen-derived dendritic cells and tumour cells.
    Ogawa F; Iinuma H; Okinaga K
    Scand J Immunol; 2004 May; 59(5):432-9. PubMed ID: 15140052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
    Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
    Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell therapy with interferon-alpha synergistically suppresses outgrowth of established tumors in a murine colorectal cancer model.
    Ishii S; Hiroishi K; Eguchi J; Hiraide A; Imawari M
    Gene Ther; 2006 Jan; 13(1):78-87. PubMed ID: 16107857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
    Cheng J; Sun J; Sung RS
    Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
    Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
    Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent antitumor effects mediated by local expression of the mature form of the interferon-gamma inducing factor, interleukin-18 (IL-18).
    Osaki T; Hashimoto W; Gambotto A; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    Gene Ther; 1999 May; 6(5):808-15. PubMed ID: 10505105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy with CX3CL1/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma.
    Tang L; Hu HD; Hu P; Lan YH; Peng ML; Chen M; Ren H
    Gene Ther; 2007 Aug; 14(16):1226-34. PubMed ID: 17597794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
    Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
    Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.
    Mazzolini G; Narvaiza I; Martinez-Cruz LA; Arina A; Barajas M; Galofré JC; Qian C; Mato JM; Prieto J; Melero I
    Gene Ther; 2003 Jul; 10(13):1067-78. PubMed ID: 12808437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
    Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
    Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.
    Morini M; Albini A; Lorusso G; Moelling K; Lu B; Cilli M; Ferrini S; Noonan DM
    Gene Ther; 2004 Feb; 11(3):284-91. PubMed ID: 14737088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus.
    Siders WM; Wright PW; Hixon JA; Alvord WG; Back TC; Wiltrout RH; Fenton RG
    J Immunol; 1998 Jun; 160(11):5465-74. PubMed ID: 9605149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
    Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
    J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.